NUP210 and breast carcinoma: We decided to examine NUP210–histone H3.1 interaction due to the potential association of H3.1 with poor outcome in breast cancer patients (P = 0.0642) in METABRIC dataset (Fig. 4c) and reported mutations of histone H3.1 in human cancer29,30.